These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 23129588

  • 1. Chronic depletion of glutathione exacerbates ventricular remodelling and dysfunction in the pressure-overloaded heart.
    Watanabe Y, Watanabe K, Kobayashi T, Saito Y, Fujioka D, Nakamura T, Obata JE, Kawabata K, Mishina H, Kugiyama K.
    Cardiovasc Res; 2013 Feb 01; 97(2):282-92. PubMed ID: 23129588
    [Abstract] [Full Text] [Related]

  • 2. Mice lacking the glutamate-cysteine ligase modifier subunit are susceptible to myocardial ischaemia-reperfusion injury.
    Kobayashi T, Watanabe Y, Saito Y, Fujioka D, Nakamura T, Obata JE, Kitta Y, Yano T, Kawabata K, Watanabe K, Mishina H, Ito S, Kugiyama K.
    Cardiovasc Res; 2010 Mar 01; 85(4):785-95. PubMed ID: 19837697
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Initial characterization of the glutamate-cysteine ligase modifier subunit Gclm(-/-) knockout mouse. Novel model system for a severely compromised oxidative stress response.
    Yang Y, Dieter MZ, Chen Y, Shertzer HG, Nebert DW, Dalton TP.
    J Biol Chem; 2002 Dec 20; 277(51):49446-52. PubMed ID: 12384496
    [Abstract] [Full Text] [Related]

  • 6. Knockout of the mouse glutamate cysteine ligase catalytic subunit (Gclc) gene: embryonic lethal when homozygous, and proposed model for moderate glutathione deficiency when heterozygous.
    Dalton TP, Dieter MZ, Yang Y, Shertzer HG, Nebert DW.
    Biochem Biophys Res Commun; 2000 Dec 20; 279(2):324-9. PubMed ID: 11118286
    [Abstract] [Full Text] [Related]

  • 7. Polymorphism in glutamate-cysteine ligase modifier subunit gene is associated with impairment of nitric oxide-mediated coronary vasomotor function.
    Nakamura S, Sugiyama S, Fujioka D, Kawabata K, Ogawa H, Kugiyama K.
    Circulation; 2003 Sep 23; 108(12):1425-7. PubMed ID: 12975258
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Glutathione deficiency in Gclm null mice results in complex I inhibition and dopamine depletion following paraquat administration.
    Liang LP, Kavanagh TJ, Patel M.
    Toxicol Sci; 2013 Aug 23; 134(2):366-73. PubMed ID: 23704229
    [Abstract] [Full Text] [Related]

  • 15. Lack of maternal glutamate cysteine ligase modifier subunit (Gclm) decreases oocyte glutathione concentrations and disrupts preimplantation development in mice.
    Nakamura BN, Fielder TJ, Hoang YD, Lim J, McConnachie LA, Kavanagh TJ, Luderer U.
    Endocrinology; 2011 Jul 23; 152(7):2806-15. PubMed ID: 21558310
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Polymorphism in the 5'-flanking region of human glutamate-cysteine ligase modifier subunit gene is associated with myocardial infarction.
    Nakamura S, Kugiyama K, Sugiyama S, Miyamoto S, Koide S, Fukushima H, Honda O, Yoshimura M, Ogawa H.
    Circulation; 2002 Jun 25; 105(25):2968-73. PubMed ID: 12081989
    [Abstract] [Full Text] [Related]

  • 19. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP, Chakrabarty A, Shipp N, Molaee P, Madsen PL, Joerg L, Sullivan T, Worthley SG, De Pasquale CG, Sanders P, Selvanayagam JB.
    Eur Heart J; 2012 Mar 25; 33(5):640-8. PubMed ID: 22048681
    [Abstract] [Full Text] [Related]

  • 20. Olmesartan attenuates cardiac remodeling through DLL4/Notch1 pathway activation in pressure overload mice.
    You J, Wu J, Jiang G, Guo J, Wang S, Li L, Ge J, Zou Y.
    J Cardiovasc Pharmacol; 2013 Feb 25; 61(2):142-51. PubMed ID: 23188126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.